CAI — Caris Life Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2019410 ·
Last close
$17.60
Market Cap
$4.98B
52W High
$22.16
52W Low
$14.19
ADV30
2,916,418
Next earnings
2026-05-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 216,174,000 | 141,348,000 | 5,282,000 | -510,000 | 1,162,388,000 | 821,147,000 | 568,898,000 |
| Dec 2025 | 292,886,000 | 220,914,000 | 88,411,000 | 81,957,000 | 1,125,663,000 | 796,274,000 | 548,356,000 |
| Sep 2025 | 216,833,000 | 147,506,000 | 32,642,000 | 24,325,000 | 984,571,000 | 753,221,000 | 506,207,000 |
| Jun 2025 | 181,398,000 | 113,685,000 | -17,989,000 | -71,790,000 | 955,058,000 | 718,934,000 | 502,154,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$83,155,000
Investing CF
$-16,260,000
Financing CF
$664,989,000
CapEx
$-16,260,000
Dividends Paid
—
Buybacks
$-113,000
EPS Diluted TTM
$-8.01
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,548,736,000
Inventory
$63,625,000
Receivables
$112,140,000
ST Investments
$2,295,000
EBIT TTM
$-11,236,000
Pretax Income TTM
$-68,089,000
Interest Exp TTM
$56,853,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$907,292,032
EBITDA
$128,981,000
Free Cash Flow
$102,059,248
Enterprise Value
$4,582,676,480
Total Cash
$823,462,016
Total Debt
$430,958,016
Shares Out
282,680,695
Trailing EPS
$-2.76
Book Value
$2.10
ROE
28.4%
ROA
9.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 812,033,000 | 45,113,000 | -68,088,000 | 1,125,663,000 | 548,356,000 | — | 83,155,000 |
| Dec 2024 | 412,260,000 | -257,122,000 | -281,890,000 | 343,734,000 | 2,842,572,000 | — | -245,199,000 |
| Dec 2023 | 306,128,000 | -319,551,000 | -341,415,000 | 412,900,000 | 2,557,850,000 | — | -276,100,000 |
| Dec 2022 | 258,485,000 | -315,756,000 | -320,827,000 | 717,422,000 | 2,419,535,000 | — | -285,706,000 |
TTM Snapshot
Revenues TTM
$101,620,000
NetIncome TTM
$-67,729,000
OpCashFlow TTM
$0
Assets (Latest)
$343,734,000
Forward EPS
$0.37
Max Pain — expiry 2026-07-17
max pain strike: $17.50 · spot: $18.34 · call oi: 2,536 · put oi: 779
Expected Move to 2026-07-17:
±$3.15
(17.18%) —
implied range
$15.19 –
$21.49
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SHC | Sotera Health Co | $4.52B | $15.84 | — |
| RDNT | RadNet, Inc. | $4.42B | $56.20 | — |
| CELC | Celcuity Inc. | $4.40B | $90.21 | — |
| BLLN | BillionToOne, Inc. | $4.32B | $104.28 | — |
| VCYT | VERACYTE, INC. | $4.29B | $53.79 | — |
News headlines (Yahoo Finance, 1h cache)
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
2026-06-19 14:59 · Yahoo
Caris Life Sciences (CAI) Announces $100M Share Repurchase Program
2026-06-17 19:38 · Yahoo
Caris Life Sciences Announces That It’s Dual Listing on NYSE Texas
2026-06-16 15:26 · Yahoo
Caris Life Sciences Announces Dual Listing on NYSE Texas
2026-06-16 12:30 · Yahoo
Caris Life Sciences Announces Share Repurchase Program
2026-06-08 12:30 · Yahoo
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
2026-05-26 12:30 · Yahoo
You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees.
2026-05-20 17:34 · Yahoo
Caris Life Sciences Advances Precision Oncology As Shares Trade Below Targets
2026-05-19 19:06 · Yahoo
Another billionaire dumps mega-cap stock for AI bet
2026-05-18 02:03 · Yahoo
Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.
2026-05-15 21:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.